BlueRidge Life Sciences Pharmaceutical Commercialization’s Dr. Naomi Sacks’s work published in Obesity Science & Practice on behalf of The Obesity Society was recently… read more
Dr. Naomi Sacks, HEORStrategies Vice President, is a co-author on a recently published study, “Impact of Demographics and Insurance Coverage on Schizophrenia Treatment… read more
Partnership between leading pharmaceutical solution providers enhances offerings across pharmaceutical development and commercialization August 13, 2024 –Katy, Texas — ToxStrategies, a leading… read more
HEORStrategies’ scientist Dr. Naomi Sacks, along with clinicians and industry leaders, is a co-author of a study just published in Orphanet Journal of Rare… read more
Partnership of leading scientific service providers enhances offerings for pharmaceutical clients June 25, 2024 –Katy, Texas – ToxStrategies, a best-in-class, multidisciplinary scientific consulting… read more
EpidStrategies’ epidemiologists have collaborated with other researchers on three publications that describe healthcare utilization in 80,000 infants covered by Medicaid, as well as… read more
Dr. Naomi Sacks, Vice President, HEORStrategies, a Division of ToxStrategies LLC, is at the annual meeting of ISPOR (The Professional Society for Health… read more
HEORStrategies’ scientist Dr. Naomi Sacks, along with clinicians and industry leaders, is presenting results of a study of antibiotic treatment patterns and treatment failure… read more